适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- Argenx
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
1 期
A Phase 1, Open-Label Study to Investigate the TARP-?8 Receptor Occupancy of RAP-219 Using a TARP-?8 PET Tracer in Healthy Adult ParticipantsMedDRA version: 21.0Level: PTClassification code: 10015037Term: Epilepsy Class: 100000004852EpilepsyCTIS2024-512151-21-00Rapport Therapeutics Inc.24
进行中（未招募）
1 期
First administration in healthy volunteers of a single and increasing dose of a new molecule for the treatment of brain diseasesPost-Traumatic Stress Disorder (PTSD)MedDRA version: 21.1Level: PTClassification code: 10036316Term: Post-traumatic stress disorder Class: 100000004873CTIS2023-505030-99-00Rest Therapeutics36
进行中（未招募）
1 期
Randomised, crossover bioavailability clinical trial of oral minoxidil 1 mg, after single and multiple dose administration to healthy volunteers under fasting conditionsAndrogenetic alopeciaCTIS2023-503796-14-00Industrial Farmaceutica Cantabria S.A.14
进行中（未招募）
1 期
A Phase 1b study of inhaled RCT1100 in Adults with Primary Ciliary Dyskinesia Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary ClearanceCTIS2023-510521-14-00Recode Therapeutics Inc.12
招募中
1 期
Phase 1 study assessing the pharmacokinetics of NEX-22A in subjects with T2DCTIS2023-508054-25-01anexa AB9